Services

Online Inquiry

Your Name

Phone Number

* E-mail Address

* Services Interested

Project Description

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

siRNA Nucleotide Base Modification

At Protheragen BioNucleics, we are committed to pioneering innovations in oligonucleotide therapeutics. Leveraging our comprehensive Oligonucleotide Drugs CRO Services, specialized Oligonucleotide Modification Service, and dedicated siRNA Modification Service, we strive to enhance the efficacy and safety of siRNA-based therapies.

Overview of siRNA Nucleotide Base Modification

Small interfering RNA (siRNA) has revolutionized gene silencing techniques, offering precise targeting of mRNA transcripts to inhibit protein synthesis. Despite its potential, unmodified siRNA molecules often face challenges such as degradation by nucleases, off-target effects, and limited cellular uptake. Nucleotide base modification emerges as a critical strategy to overcome these hurdles. By chemically altering the nucleobases within siRNA strands, we can enhance stability, specificity, and overall therapeutic performance, propelling siRNA therapies closer to clinical reality.

Our Services

At Protheragen BioNucleics, we offer a comprehensive suite of siRNA nucleotide base modification services designed to optimize your therapeutic projects:

Customized Nucleobase Modifications

We provide a range of nucleobase modifications tailored to enhance siRNA properties:

5-Methylcytosine and 5-Hydroxymethylcytosine Incorporation: Enhances binding affinity and reduces immune recognition.
Pseudo-uridine Substitution: Improves thermal stability and nuclease resistance.
Locked Nucleic Acid (LNA) Bases: Increases target specificity and duplex stability.
Base Analogues: Introduction of non-natural bases to fine-tune hybridization characteristics.

Advanced Chemical Synthesis Techniques

Our expertise in oligonucleotide chemistry enables precise modification:

Solid-Phase Synthesis Optimization: Utilizing advanced phosphoramidite chemistry for high-fidelity incorporation.
Liquid-Phase Synthesis Enhancement: Employing optimized liquid-phase synthesis methods to improve reaction kinetics and yield of modified siRNA.
Click Chemistry Conjugation: Facilitating the attachment of functional groups without compromising siRNA integrity.
Enzymatic Incorporation Methods: Employing enzymes for selective base modification when chemical methods are unsuitable.

Modification Pattern Design and Analysis

We assist in designing optimal modification patterns:

Computational Modeling: Predicting the effects of modifications on siRNA structure and function.
Sequence Alignment and Off-Target Prediction: Ensuring high specificity to the target mRNA.
Thermodynamic Profiling: Assessing the stability of modified siRNA duplexes.

Quality Control and Analytical Services

Ensuring the highest quality of modified siRNA products:

Mass Spectrometry and HPLC Analysis: Confirming molecular weight and purity.
UV Spectroscopy: Determining concentration and assessing base composition.
Functional Assays: Evaluating gene silencing efficiency in vitro.

Scale-Up Production and Regulatory Support

We support projects from research to preclinical development:

Flexible Scale Synthesis: From microgram to gram quantities to meet various project demands.
GMP Manufacturing: Compliant production for clinical trial materials.
Regulatory Documentation: Providing necessary documentation for regulatory submissions.

Frequently Asked Questions

Q1: How do nucleotide base modifications improve siRNA therapeutic applications?

Nucleotide base modifications enhance siRNA stability against enzymatic degradation, reduce immunogenicity, and increase binding specificity to target mRNA. These improvements lead to more efficient gene silencing and reduced off-target effects, which are crucial for therapeutic efficacy.

Q2: Can you assist in selecting the most suitable modifications for my siRNA project?

Absolutely. Our team of experts will collaborate with you to understand your project’s goals and recommend the most effective nucleotide base modifications based on empirical data and computational predictions.

Q3: Do you offer siRNA conjugation services for targeted delivery?

Yes, we provide conjugation services, including the attachment of ligands such as peptides, antibodies, or small molecules, to facilitate targeted delivery and improve cellular uptake of siRNA molecules.

Why Choose Us

Expertise in Nucleic Acid Chemistry: Our team possesses deep knowledge and experience in siRNA modification technologies.
Customized Solutions: We tailor our services to meet the specific needs of your project, ensuring optimal outcomes.
Advanced Facilities: Equipped with advanced technology to deliver high-quality products efficiently.
Comprehensive Support: From initial consultation to final delivery, we provide continuous support and open communication.

Our services and products are exclusively for authorized organizations in research, development, or manufacturing and are not intended for direct use by individuals or patients or as medical advice, diagnosis, or treatment.